Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

J Clin Invest. 2019 May 1;129(5):2164. doi: 10.1172/JCI129277. Epub 2019 May 1.
No abstract available

Publication types

  • Published Erratum